– UK, Sheffield – Benchmark Holdings PLC (AIM: BMK), the aquaculture health, advanced nutrition, and genetics business announces the appointment of Peter George as Chairman of the Board with immediate effect. As announced on 31st January 2018, Alex Hambro will retire from the Board on Peter’s appointment and will ensure an orderly handover.
Peter has a strong track record in growing successful international pharmaceutical and healthcare businesses. He is most renowned for his achievements as CEO of Clinigen Group plc, the FTSE AIM global pharmaceutical and services company, which he founded in 2010 and grew into close to a £1bn market cap company having acquired several businesses and expanded its international footprint.
Peter now serves as Chairman of Ergomed plc, the AIM-listed provider of clinical research, drug development and safety services internationally. He is also an Entrepreneur in Residence at Oxford Science Innovations.
Prior to Clinigen, he held a number of senior roles in the pharmaceutical and healthcare sectors including Chief Executive Officer of Penn Pharmaceutical Services. He co-created Unilabs Clinical Trials International in 1997, which was successfully sold to Icon plc in 2000.
Peter George, incoming Chairman commented: “I am delighted to lead the Board of Benchmark Holdings. I have been impressed by the strength of Benchmark’s position in aquaculture, its products, scale and global distribution network. There are many exciting prospects for us and, as Chairman I intend to work closely with the Board to help deliver shareholder value and continue to develop the Company’s leading position in aquaculture.”
Malcolm Pye, Benchmark CEO commented: “I am delighted to welcome Peter George to our Board as Chairman. He has a wealth of experience and a demonstrable track record in delivering shareholder value. I look forward to working closely with him as we continue to drive growth across our organisation.”
Alex Hambro, Benchmark’s retiring Chairman commented: “I am very pleased Benchmark has taken on Peter George. I have no doubt he will be instrumental in guiding the Company through its next phase of growth and I wish him, the Board and Benchmark’s management team every success in the future.”
About Benchmark Holdings PLC
Benchmark challenges the status quo in aquaculture. Since 2000, Benchmark has consistently worked to build a technology-rich platform in the areas of genetics, advanced nutrition, animal health and knowledge services, to serve its customers, helping them take control of their biological environment to improve yield and efficiency in a sustainable way.
The Company has leading positions in its core markets and established R&D, manufacturing and distribution capabilities to serve all the major aquaculture markets. Benchmark operates in 27 countries in five continents and as at 30 September 2017, it employed 950 people.
For more information : http://www.benchmarkplc.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
